Research > ETFs > ETF / ETP Commentary > 

Tailwinds Lifting Healthcare and "CURE" ETF

Innovation-driven by rising demands on the healthcare system can create a strong growth environment for traders using the Direxion Daily Healthcare Bull 3X ETF (CURE A-).The rising population and improved medical technology is causing individuals to live longer. As such, the healthcare system will be forced to take care of an aging population, which could help drive innovative technologies in administering care.“Innovation in the medical arena is poised to accelerate over the next decade,” an Investorplace article noted. “Aging demographic trends stateside and across the world, along with rapid advances in technology, should create significant growth opportunities for healthcare stocks.”The pandemic only accelerated this need for more innovative healthcare technology. As such, this is certainly opening up opportunities for investors in the healthcare sector.“The pandemic has been forcing healthcare providers to adopt new tools,” the article added. “And the aging and growing global population fuels demand for innovative treatments. As a result, companies that successfully merge healthcare and technology should be at the top of the shopping list of all long-term investors.”In addition, short-term investors who want to utilize leverage can also stand to benefit. Enter funds like CURE, where traders can play the short-term fluctuations in healthcare, particularly if they’re looking for a bullish slant.Triple the Leverage, Triple the GainsCURE seeks daily investment results equal to 300% of the daily performance of the Health Care Select Sector Index. The fund achieves this exposure by investing at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index.The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals, healthcare equipment, and supplies; healthcare providers and services; biotechnology; life sciences tools and services; and more. These sub-industries have all been affected by the pandemic in some form or fashion, giving traders dynamic opportunities to play the market.Up 72% for the year, bulls have been on the right side of the healthcare trade in 2021. In terms of technical trading, short-term and long-term momentum are showing strength with the 50-day and the 200-day moving average in uptrends.The relative strength index is heading towards overbought levels, but any subsequent price adjustment could be an entry point. CURE has been trading above its 50-day moving average since the start of summer so that near-term strength could persist through the year.CURE data by YChartsFor more news and information, visit the Leveraged & Inverse Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.